After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, DYN falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Dyne Therapeutics Inc is $1.64B. A total of 3.6 million shares were traded on the day, compared to an average of 2.44M shares.
In the most recent transaction, Cox John sold 4,060 shares of DYN for 13.35 per share on Jun 05 ’25. After the transaction, the CEO & President now owns 142,179 company shares. In a previous transaction on Jun 05 ’25, Kerr Douglas sold 1,342 shares at 13.35 per share. DYN shares that Chief Medical Officer owns now total 92,815.
Among the insiders who sold shares, Friedl-Naderer Johanna disposed of 146 shares on Jun 05 ’25 at a per-share price of $13.35. This resulted in the Chief Commercial Officer holding 95,911 shares of DYN after the transaction. In another insider transaction, Kerr Douglas bought 1,342 shares at $13.35 per share on Jun 05 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DYN has a high of $47.45 and a low of $6.36.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $5.89, while its Total Shareholder’s Equity was $368.20M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DYN is Buy with a score of 4.80.
